Category: Hot Opportunities

Shares of the Molecular Data Inc. (MKD) stock rose in the Pre-market today on September 24, 2021. MKD stock price saw a push of 3.78% to reach $0.31 a share at the time of this writing. It seems that Molecular stock is continuing the rising momentum as it went up by 5.17% at the previous closing. Let’s understand the reason behind this bull. What’s Happening? There seems to be no press release or specific news by Molecular Data in today’s date to support the ongoing rally. No analysts’ upgrades or increased targeted per share price of MKD stock has been

Uxin Limited (UXIN) saw a push of 9.46% in the premarket after the company reported unaudited the first quarter of the fiscal year 2022 results. However, the last trading session closed at $2.96 with an incline of 2.78%. First Quarter of Fiscal Year 2022 Results UXIN announced the results of the first quarter of the fiscal year 2022 on 24th September 2021. For the three months ending June 30, 2021, total revenues were RMB277.8 million (US$43.0 million). The increase was largely attributable to higher gross revenue recognized from September 2020. This was a consequence of the Company selling used vehicles

Color Start Technology Co. Ltd. (CSCW) stock prices were down by 1.47% as of the market closing on September 23rd, 2021. This brought the price per share down to USD$0.87 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 2.25%, bringing it up to USD$0.89. CSCW Stock to Acquire Chujing September 23rd, 2021 saw the company announce the official signing of an agreement of intent to acquire Chujing Esports. The collaboration will aim to develop a global esports pan-entertainment sector combing each company’s respective industry advantages. CSCW stock will also include this new

Minerva Neurosciences, Inc. (NERV) has seen a push of 6.52% in the premarket today. However, the last trading session closed at $1.84 with an incline of 9.52%. Appointment of Dr. Ramana Kuchibhatla as Senior Vice President and Head of Research & Development NERV announced the appointment of Dr. Ramana Kuchibhatla on 8th September 2-2021. Dr. Ramana Kuchibhatla’s is appointed as Senior Vice President and Head of Research and Development. Firstly, Dr. Kuchibhatla has over 35 years of expertise in the life sciences and biotechnology sectors. This includes drug development, regulatory, biostatistical, and operations leadership. He comes to Minerva from PRA

In addiiGlycoMimetics, Inc. (GLYC) has seen an increase of 2.62% after GLYC announced Efficacy and Safety Data for GlycoMimetics’ Lead Investigational Drug Uproleselan. However, the last trading session closed at $2.29 with an incline of 3.15%. Efficacy and Safety Data for GlycoMimetics’ Lead Investigational Drug Uproleselan by GLYC GLYC announced on 23rd September 2021 that the Efficacy and Safety Data for GlycoMimetics’ Lead Investigational Drug Uproleselan are Published in BLOOD. However, the researchers emphasize an examination of minimum residual disease (MRD). They found a 69 percent MRD negative rate in trial participants with relapsed/refractory acute myeloid leukemia (AML). This will

InnSuites Hospitality Trust (IHT) experiences a decline of 7.62% in the aftermarket. However, the last trading session closed at $5.12 with an increase of 45.87%. First Quarter Profit IHT reported a first-quarter profit on 28th June 2021. The company recorded a profit of $157,161 in the fiscal first quarter. It was more than $500,000 over the same time the previous year $352,857. For the fiscal first quarter of 2022, which ended on April 30, 2021, revenues were around $1.4 million. This was essentially unchanged compared to revenues of around $1.4 million for the same time the previous year. For the

TransCode Therapeutics, Inc. (RNAZ) stock Popped high today after it announced the publication in Cancer Nanotechnology. RNAZ stock price saw a surge of 57.44% to reach $4.12 a share at the time of this writing. The trading volume as of now was 44,010,588. RNAZ stock has lost almost 19% in the last 12 months. TransCode Therapeutics, Inc is the biopharmaceutical stock that develops and commercializes drugs to treat metastatic diseases. Its lead product candidate is TTX-MC138, a pre-clinical stage product that patients use against metastatic cancer. What’s Happening? RNAZ stock today announced preclinical research publication for TTX-MC138 in Cancer Nanotechnology

Northern Dynasty Minerals Ltd. (NAK), a company engaged in the exploration of mineral properties in the United States, has seen a gain of 9% in the premarket trading session. As a result, NAK stock is changing hands at $0.51 at the time of this writing. On Wednesday, NAK stock closed the day at $0.47 after gaining 0.32% in regular hours. The reason behind this rise appears to be a new filing in Bristol Bay Economic Development vs. Pirzadeh case, where, Pebble Ltd. partnership was granted intervention rights. That development has come after the Biden administration pledge for the protection of

Amarin Corporation PLC (AMRN) stock prices were up by 3.12% as of the market closing on September 22nd, 2021. This brought the price per share up to USD$5.29 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 2.08%, bringing it up to USD$5.40. AMRN Stock’s New Strategy September 22nd, 2021 saw AMRN stock outline its new Go-to-Market strategy to accelerate the growth of VASCEPA in the United States. The strategy focuses on the expansion of healthcare professional engagement via a new omnichannel platform. This will enhance managed care access and optimize VASCEPA prescriptions

OptiNose Inc. (OPTN) stock prices were down by 1.08% as of the market closing on September 22nd, 2021. This brought the price per share down to USD$2.75 at the end of the trading day. Subsequent premarket fluctuations saw the stock surge by 7.27%, bringing it up to USD$2.95. OPTN Stock’s Presentation September 22nd, 2021 saw OPTN stock announce the provision of a company overview and business update. CEO Peter Miller will present at the Cantor Virtual Global Healthcare Conference on September 28th, 2021. A live stream of the webcast will be available on the Investors page on the company’s website.